These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s]. Magnusson C; Reeves G Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095 [No Abstract] [Full Text] [Related]
5. Justification for the use of HRT in the long-term prevention of osteoporosis. Stevenson JC Maturitas; 2005 Jun; 51(2):113-26. PubMed ID: 15917151 [TBL] [Abstract][Full Text] [Related]
6. Hormone therapy and breast cancer risk. Foidart JM; Desreux J; Pintiaux A; Gompel A Climacteric; 2007 Oct; 10 Suppl 2():54-61. PubMed ID: 17882674 [TBL] [Abstract][Full Text] [Related]
7. Use of dydrogesterone in hormone replacement therapy. Mueck AO; Seeger H; Bühling KJ Maturitas; 2009 Dec; 65 Suppl 1():S51-60. PubMed ID: 19836909 [TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy and risk of breast cancer: the role of progestins. Stahlberg C; Pedersen AT; Lynge E; Ottesen B Acta Obstet Gynecol Scand; 2003 Apr; 82(4):335-44. PubMed ID: 12716318 [TBL] [Abstract][Full Text] [Related]